Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2081057 | Drug Discovery Today | 2009 | 8 Pages |
Abstract
The problem of how to explore structure–activity relationships (SARs) systematically is still largely unsolved in medicinal chemistry. Recently, data analysis tools have been introduced to navigate activity landscapes and to assess SARs on a large scale. Initial investigations reveal a surprising heterogeneity among SARs and shed light on the relationship between ‘global’ and ‘local’ SAR features. Moreover, insights are provided into the fundamental issue of why modeling tools work well in some cases, but not in others.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Jürgen Bajorath, Lisa Peltason, Mathias Wawer, Rajarshi Guha, Michael S. Lajiness, John H. Van Drie,